PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE

摘要

The present disclosure relates to PDE9 inhibitors, pharmaceutical compositions comprising the PDE9 inhibitors, and methods of using the PDE9 pharmaceutical compositions for the treatment of sickle cell disease (SCD).